<DOC>
	<DOCNO>NCT01556997</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy fixed-dose combination drug compare two drug ( monotherapies ) control hypertension .</brief_summary>
	<brief_title>Perindopril Amlodipine Treatment Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<criteria>Essential hypertension For female subject , negative serum pregnancy test Ability provide write informed consent Night shift worker whose work hour include midnight 4:00 a.m . Secondary hypertension An arm size precludes use digital blood pressure monitor cuff ( arm size &gt; 42 cm ) Renal dysfunction , severe renal impairment , bilateral renal artery stenosis , renal artery stenosis solitary kidney , subject 1 kidney , postrenal transplant subject Female subject pregnant , plan become pregnant History malignancy within 5 year Primary aldosteronism Heart failure ( NYHA functional class 34 ) , hypertrophic obstructive cardiomyopathy , hemodynamically relevant stenosis aortic mitral valve Significant cardiac arrhythmia , MI , stroke , CABG , PTCA , unstable angina Known hypersensitivity component study drug Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Essential Hypertension</keyword>
</DOC>